EARLY BREAST CANCER
Clinical trials for EARLY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost breast cancer remission before surgery
Disease control Not yet recruitingThis study tests a new drug combination (SHR-A1811 plus pertuzumab) given before surgery to women with early or locally advanced HR-positive, HER2-positive breast cancer. The goal is to see if this approach can eliminate cancer more effectively than standard chemo, while reducing…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
Could a genetic test spare young breast cancer patients from chemo?
Disease control Not yet recruitingThis study looks at whether a genetic test (Prosigna®) can help decide if younger women with a common type of early breast cancer need chemotherapy. About 3380 premenopausal women will be randomly assigned to either standard treatment (always chemo plus hormone therapy) or a test…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New study to track why some breast cancer patients stop taking Life-Saving pills
Knowledge-focused Not yet recruitingThis study will follow 81 people with early-stage, hormone-positive breast cancer who are at high risk of the cancer coming back. Researchers want to see how often patients stop taking their prescribed CDK4/6 inhibitor pills (abemaciclib or ribociclib) before the full treatment c…
Matched conditions: EARLY BREAST CANCER
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated May 26, 2026 06:45 UTC
-
Massive korean study tracks breast cancer recurrence in 100,000 patients
Knowledge-focused Not yet recruitingThis study will look back at medical records of 100,000 people in Korea with early-stage hormone receptor-positive, HER2-negative breast cancer who had surgery and other treatments. The goal is to see how often the cancer comes back and what factors might affect that risk. No new…
Matched conditions: EARLY BREAST CANCER
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 06:45 UTC
-
Which Follow-Up therapy works best for tough breast cancers?
Knowledge-focused Not yet recruitingThis study looks at 2,000 women with HER2-positive breast cancer who still had cancer after initial treatment and surgery. Researchers compare two different drug combinations given after surgery to see which one helps prevent the cancer from coming back over three years. The goal…
Matched conditions: EARLY BREAST CANCER
Sponsor: Hebei Medical University Fourth Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC